ArticleBiology methods & protocols2026

GLP-1-based incretin therapy is associated with lower incident Alzheimer's disease and cardiorenal events in adults with documented neuropsychiatric, cognitive, or sensory risk.

Karthik Murugadoss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.